EN 3285

Drug Profile

EN 3285

Alternative Names: Acetylcysteine oral rinse - Endo; N-acetylcysteine oral rinse - Endo; NAC Oral Rinse; RK 0202

Latest Information Update: 22 Jul 2009

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Elan Corporation; RxKinetix
  • Developer Endo Pharmaceuticals
  • Class Antibronchitics; Antidotes; Expectorants; Reducing agents; Small molecules; Sulfur amino acids
  • Mechanism of Action Antioxidants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Stomatitis

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 27 Feb 2009 Discontinued - Phase-III for Stomatitis in USA (PO)
  • 08 Feb 2008 Phase-III clinical trials in Stomatitis in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top